Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Givechian, Kevin B"'
Autor:
Castro, Egbert, Godavarthi, Abhinav, Rubinfien, Julian, Givechian, Kevin B., Bhaskar, Dhananjay, Krishnaswamy, Smita
The development of powerful natural language models have increased the ability to learn meaningful representations of protein sequences. In addition, advances in high-throughput mutagenesis, directed evolution, and next-generation sequencing have all
Externí odkaz:
http://arxiv.org/abs/2201.09948
Autor:
Fijany, Arman J., Givechian, Kevin B., Zago, Ilana, Olsson, Sofia E., Boctor, Michael J., Gandhi, Rajesh R., Pekarev, Maxim
Publikováno v:
In Burns September 2023 49(6):1249-1259
Autor:
Wnuk, Kamil, Sudol, Jeremi, Givechian, Kevin B., Soon-Shiong, Patrick, Rabizadeh, Shahrooz, Szeto, Christopher, Vaske, Charles
Publikováno v:
In iScience 25 October 2019 20:119-136
Autor:
Fijany, Arman J, Chaker, Sara C, Hung, Ya-Ching, Zago, Ilana, Friedlich, Nicole, Olsson, Sofia E, Holan, Cole A, Montorfano, Lisandro, Mubang, Ronnie N, Givechian, Kevin B, Boctor, Michael J, Pekarev, Maxim, Martinez-Jorge, Jorys, Slater, Elizabeth D
Publikováno v:
Aesthetic Surgery Journal; Apr2024, Vol. 44 Issue 4, p383-393, 11p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Leitner, Brooks P., Givechian, Kevin B., Ospanova, Shyryn, Beisenbayeva, Aray, Politi, Katerina, Perry, Rachel J.
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-10 (2022)
NPJ Precision Oncology
NPJ Precision Oncology
Immunometabolism within the tumor microenvironment is an appealing target for precision therapy approaches in lung cancer. Interestingly, obesity confers an improved response to immune checkpoint inhibition in non-small cell lung cancer (NSCLC), sugg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b5048e5d6d27e0948cf9073a18cbcc6
https://doaj.org/article/3cfdbbc9a9d241b4ab20b7b2c129ff8b
https://doaj.org/article/3cfdbbc9a9d241b4ab20b7b2c129ff8b
Overexpression of RKIP and its cross-talk with several regulatory gene products in multiple myeloma.
Autor:
Shvartsur, Anna1, Givechian, Kevin B.2, Garban, Hermes3, Bonavida, Benjamin1 bbonavida@mednet.ucla.edu
Publikováno v:
Journal of Experimental & Clinical Cancer Research (17569966). 5/5/2017, Vol. 36, p1-14. 14p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Givechian KB; NantOmics LLC, Culver City, California, USA.; Medical Scientist Training Program, Yale School of Medicine, New Haven, Connecticut, USA., Garner C; ImmunityBio, Inc., El Segundo, California, USA., Benz S; NantOmics LLC, Culver City, California, USA., Rabizadeh S; NantOmics LLC, Culver City, California, USA.; ImmunityBio, Inc., El Segundo, California, USA., Soon-Shiong P; NantOmics LLC, Culver City, California, USA.; ImmunityBio, Inc., El Segundo, California, USA.
Publikováno v:
Neuro-oncology advances [Neurooncol Adv] 2020 Nov 27; Vol. 3 (1), pp. vdaa162. Date of Electronic Publication: 2020 Nov 27 (Print Publication: 2021).
Autor:
Givechian KB; NantOmics LLC, Culver City, CA 90232, USA., Garner C; NantHealth, Inc. NantWorks, Culver City, CA 90232, USA., Benz S; NantOmics LLC, Culver City, CA 90232, USA., Song B; NantOmics LLC, Culver City, CA 90232, USA., Rabizadeh S; NantOmics LLC, Culver City, CA 90232, USA.; NantHealth, Inc. NantWorks, Culver City, CA 90232, USA., Soon-Shiong P; NantOmics LLC, Culver City, CA 90232, USA.; NantHealth, Inc. NantWorks, Culver City, CA 90232, USA.; NantBioscience, Inc. NantWorks, Culver City, CA 90232, USA.
Publikováno v:
Oncotarget [Oncotarget] 2019 Mar 05; Vol. 10 (19), pp. 1840-1849. Date of Electronic Publication: 2019 Mar 05 (Print Publication: 2019).